Medicare Enrolled
Dr. Gaurav Aggarwala, M.D.
Internal Medicine · Huntsville, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aggarwala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aggarwala? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aggarwala
Dr. Gaurav Aggarwala is an internal medicine in Huntsville, TX, with 19 years in practice. Based on federal Medicare data, Dr. Aggarwala performed 12,280 Medicare services across 3,895 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aggarwala received a total of $56,204 from 65 pharmaceutical and/or device companies across 702 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aggarwala is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 3% volume in TX$ $56,204 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,280
Medicare services
Top 3% in TX for internal medicine
3,895
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~646 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 2,139 | $11 | $46 |
| Remote patient monitoring management, 20 min/month | 917 | $37 | $150 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 917 | $30 | $123 |
| Office visit, established patient (30-39 min) | 841 | $92 | $385 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 21 or more minutes | 790 | $36 | $145 |
| Remote patient monitoring device, 30 days | 666 | $37 | $153 |
| Allergy skin test | 651 | $3 | $13 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 525 | $26 | $272 |
| Office visit, established patient (20-29 min) | 447 | $60 | $272 |
| Regadenoson injection (Lexiscan) for heart stress test | 405 | $44 | $177 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 390 | $19 | $86 |
| Echocardiogram, transthoracic | 345 | $132 | $592 |
| Remote pacemaker/defibrillator monitoring, 90 days | 185 | $16 | $79 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 185 | $14 | $59 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 183 | $128 | $571 |
| Ultrasound study of arm and leg arteries | 179 | $53 | $249 |
| Ultrasound of leg arteries or artery grafts | 164 | $178 | $727 |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 157 | $37 | $549 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 147 | $23 | $91 |
| Chronic care management, additional 20 min/month | 141 | $38 | $50 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 140 | $17 | $102 |
| Remote pacemaker monitoring, 90 days | 138 | $21 | $98 |
| Ultrasound of both sides of head and neck blood flow | 128 | $134 | $579 |
| Chronic care management, first 20 min/month | 126 | $50 | $129 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 104 | $66 | $709 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 100 | $329 | $1,313 |
| Hospital follow-up visit, moderate complexity | 93 | $60 | $225 |
| Test to determine lung volumes using sensors | 79 | $41 | $164 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 73 | $29 | $116 |
| Test to examine how well the lungs exchange gases | 72 | $42 | $171 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 65 | $634 | $2,577 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 65 | $9 | $35 |
| Electrocardiogram (EKG), 12-lead | 63 | $9 | $46 |
| Programming of dual lead pacemaker system | 62 | $51 | $241 |
| New patient office visit (45-59 min) | 59 | $117 | $503 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 55 | $19 | $78 |
| Infectious disease DNA/RNA test | 50 | $34 | $105 |
| Evaluation of cardiac rhythm monitor system | 47 | $35 | $151 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 47 | $26 | $120 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 43 | $88 | $367 |
| Laser destruction of incompetent vein of arm or leg using imaging guidance | 38 | $734 | $2,909 |
| Initial hospital admission, moderate complexity | 38 | $98 | $429 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 31 | $41 | $168 |
| Hospital follow-up visit, low complexity | 31 | $38 | $122 |
| Blood draw (venipuncture) | 25 | $8 | $9 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 21 | $156 | $644 |
| Cardiac catheterization | 19 | $330 | $2,890 |
| Insertion of heart rhythm monitor under skin | 18 | $71 | $5,849 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 15 | $34 | $105 |
| Complete ultrasound scan behind abdominal cavity | 13 | $73 | $330 |
| Detection test by nucleic acid for multiple types influenza virus | 12 | $94 | $287 |
| Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique | 12 | $34 | $105 |
| Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique | 12 | $69 | $211 |
| 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 12 | $50 | $154 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.5% high complexity
10.4% medium
83.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$56,204
Total received (2018-2024)
Avg $8,029/year across 7 years
Top 2% in TX for internal medicine
65
Companies
702
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$23,024 (41.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,110 (35.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$12,829 (22.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$241 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,494
2023$4,413
2022$1,921
2021$2,141
2020$2,809
2019$17,189
2018$24,237
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$23,024
Abbott Laboratories
$10,183
BIOTRONIK INC.
$5,028
Janssen Pharmaceuticals, Inc
$3,883
Medtronic, Inc.
$1,884
Philips Electronics North America Corporation
$1,591
Amgen Inc.
$1,284
AngioDynamics, Inc.
$810
CORDIS US CORP.
$683
Novartis Pharmaceuticals Corporation
$610
Sirtex Medical Inc
$550
Impulse Dynamics (USA) Inc.
$546
PFIZER INC.
$482
Merck Sharp & Dohme LLC
$466
AstraZeneca Pharmaceuticals LP
$406
Actelion Pharmaceuticals US, Inc.
$327
E.R. Squibb & Sons, L.L.C.
$305
Mylan Specialty L.P.
$261
Boston Scientific Corporation
$255
Penumbra, Inc.
$246
Reprise Biomedical, Inc.
$187
CVRx, Inc.
$182
Philips North America LLC
$171
GENZYME CORPORATION
$161
Mercator MedSystems, Inc.
$154
United Therapeutics Corporation
$149
Medtronic USA, Inc.
$145
Merck Sharp & Dohme Corporation
$127
Acarix USA Inc.
$125
Cardinal Health 200 LLC
$121
Amarin Pharma Inc.
$120
ABIOMED
$116
Regeneron Pharmaceuticals, Inc.
$108
SI-BONE, INC.
$105
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$103
Avinger Inc.
$92
Tactile Systems Technology Inc
$90
Astellas Pharma US Inc
$85
Boehringer Ingelheim Pharmaceuticals, Inc.
$82
Cardinal Health 200, LLC
$76
Opsens Inc.
$75
Kestra Medical Technology Services, Inc.
$74
Galderma Laboratories, L.P.
$66
BOSTON SCIENTIFIC CORPORATION
$63
Gilead Sciences, Inc.
$59
Esperion Therapeutics, Inc.
$54
ConvaTec Inc.
$52
Regeneron Healthcare Solutions, Inc.
$48
ARALEZ PHARMACEUTICALS US INC.
$47
SANOFI-AVENTIS U.S. LLC
$40
Organogenesis Inc.
$38
Lilly USA, LLC
$32
Venclose Inc.
$26
Medline Industries, Inc.
$24
Merit Medical Systems Inc
$22
Alnylam Pharmaceuticals Inc.
$21
Kiniksa Pharmaceuticals International, plc
$19
Siemens Medical Solutions USA, Inc.
$18
Allergan Inc.
$18
Terumo Medical Corporation
$17
ARBOR PHARMACEUTICALS, INC.
$15
KCI USA, Inc.
$15
CashFlow Solutions, LLC
$14
iRhythm Technologies, Inc.
$13
Bardy Diagnostics, Inc.
$10
Top 3 companies account for 68.0% of total payments
Associated products mentioned in payments ›
(4067) Tack Endo Sys BTK · (5023) DS Zenition 70 · (6536) Phoenix · (6554) Periph Vasc Undiv · (6554) Peripheral Vascular Undivided · (6585) Omniwire · (BH4) IGT Devices Undivided · ABRE · AIRSUPRA · ANGIO-SEAL · ANGIOJET · AQUAMANTYS · AURYON LASER SYSTEM 100-120 VAC · AZURE XT DR MRI SURESCAN · Acticor · Acticor 7 VR-T DX · Arcalyst · Asahi Fielder coronary guide wire · Asahi Sion guide wire · Assure WCD · BELSOMRA · BIOMONITOR · BRILINTA · BRITE TIP RADIANZ · BYSTOLIC · Barostim Neo System · Bullfrog · CADScor System · CAMZYOS · CHANTIX · CONFIRM RX · CRESEMBA · CROME DR MRI SURESCAN · Carnation Ambulatory Monitor · Clarivein · Confirm Rx · Connectivity and Remote care · Corlanor · Dragonfly OCT · ELIQUIS · ELLIPSYS VASCULAR ACCESS SYSTEM · EMGALITY · ENTRESTO · EVRSF · Edarbyclor · Edora · Edora 8 DR-T · EnSite Precision Cardiac Mapping System · FABRAZYME · FARXIGA · FLEXITOUCH · Flexitouch Plus · GENERAL THROMBECTOMY · GENERAL GUIDEWIRES · GENERAL THROMBECTOMY · GENERAL VASCULAR INTERVENTION · Hi-Torque Pilot guide wire · Hi-Torque Whisper guide wire · IGT D Peripheral · IGT Devices Und · IGT_D Peripheral · INNOVA · INNOVAMATRIX AC · INTELLIS ADAPTIVESTIM · INVOKANA · Impella · Indigo System · JARDIANCE · LEQVIO · LEXISCAN · LOKELMA · LUX-Dx Insertable Cardiac Monitor · LYMPHA PRESS OPTIMAL PLUS(US) BT · LifeVest · MERLIN@HOME · MRI Ready Leads · MYNX CONTROLTM · MYNXGRIP · Merlin Connectivity and Remote · Mini Trek catheters · Miro3D · Multi-Link Mini Vision coronary stent system · MynxGrip Vascular Closure Device · NC TREK coronary catheters · NEXLETOL · ONPATTRO · OPSUMIT · OPTIMIZER · ORENITRAM · Optimizer · Optis Coronary Imaging System · OptoWire · Orsiro Mission · PAMIRA · PANTHERIS · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRIMO MRI DR SURESCAN · PROCLAIM · Perclose ProGlide suture mediated closure system · PlasmaBlade · Plexa ProMRI · Puraply · Quartet CRT Lead · RADIAL 360 · REMODULIN · Repatha · Reveal LINQ · Rivacor · Rivacor 7 DR-T · S.M.A.R.T. CONTROL Self-Expanding Nitinol Stent · SIR-Spheres Microspheres · SLEEK RX PTA Dilation Catheter · SNAP · Solia · Supera peripheral stent system · TYVASO · Trilogy 100 · Turbo Elite · UPTRAVI · VENACURE 1470 PRO · VENASEAL · VERQUVO · Vascepa · VenaCure 1470 Pro · VenaSeal · WATCHMAN · XARELTO · Xience Alpine cornary stent system · Xience Sierra Coronary Stent System · Xience V coronary stent system · YUPELRI · Yupelri · ZEPHYR · ZIO Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 2% for internal medicine in TX.
Equivalent to $458 per 100 Medicare services performed
Geographic Context
Internal Medicines within 10 mi
38
Per 100K population
48.5
County median income
$49,862
Nearest hospital
HUNTSVILLE MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Aggarwala is a clinical cardiology specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (mixed engagement, top 2%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Aggarwala experienced with online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes?
Based on Medicare claims data, Dr. Aggarwala performed 2,139 online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aggarwala receive payments from pharmaceutical companies?
Yes. Dr. Aggarwala received a total of $56,204 from 65 companies across 702 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aggarwala's costs compare to other internal medicines in Huntsville?
Dr. Aggarwala's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aggarwala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicines in Huntsville
Browse internal medicines in Huntsville ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicines in TX
Internal Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicines in TX
Which TX internal medicines receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology